Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127532962 | 12753296 | 2 | F | 20151202 | 20160916 | 20160919 | PER | US-LUPIN PHARMACEUTICALS INC.-2015-03880 | LUPIN | 0.00 | F | Y | 59.02000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127532962 | 12753296 | 1 | PS | CEFUROXIME AXETIL. | CEFUROXIME AXETIL | 1 | Oral | F500760 | 65135 | 500 | MG | BID | |||||||
| 127532962 | 12753296 | 2 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0 | 1 | MG | TID | ||||||||
| 127532962 | 12753296 | 3 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127532962 | 12753296 | 1 | Pharyngitis |
| 127532962 | 12753296 | 2 | Sleep disorder |
| 127532962 | 12753296 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127532962 | 12753296 | Oral pruritus | |
| 127532962 | 12753296 | Throat irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |